Lizardi-Cervera J

Idioma: Español
Referencias bibliográficas: 6
Paginas: 484-485
Archivo PDF: 57.76 Kb.

FRAGMENTO

Objetivos: conocer las diferencias de la hepatitis crónica por virus C (VHC) y la respuesta al tratamiento entre la población caucásica y latina.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Mendez-Sanchez N, Villa AR, Chavez-Tapia NC, et al. Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data. Ann Hepatol 2005; 4: 52-5.

2. Alter MJ, Kruszon-Moran D, Aniñan O, et al. The prevalence on hepatitis C virus infection in the United States 1998 through 1994. N Engl J Med 1999; 341: 556-62.

3. Mendez-Sanchez N, Ponciano-Rodriguez G, Chavez-Tapia NC, et al. Prevalence of hepatitis C infection in a population of asymptomatic people in a checkup unit in Mexico city. Dig Dis Sci 2005; 50: 733-7.

4. Tedaldi EM, Hullseik KH, Malvestutto CD, et al. Prevalence and characteristics of heptitis C virus coinfection in a human immunodeficiency virus clinical trial group: The Terry Bern Community Programas for Clinical Research on AIDS. Clin Infec Dis 2003; 36: 1313-7.

5. Vera de Leon L, Juarez NJA, Diaz GM, et al. Epidemiologic and situational panorama of hepatitis C in Mexico. Rev Gastroenterol Mex 2005; 70: 25-32.

6. Bonacini M, Groshen MD, Yu MC, et al. Chronic hepatitis C in ethnic minority patients evaluated in Los Angeles County. Am J Gastroenterol 2001; 96: 2438-41.